Dan Shores at Medmarc Webinar on mRNA Patent Wars Update, Including Expansion of Litigations and Key Ruling Expected in 2025
Partner Dan Shores will present a webinar titled "mRNA Patent Wars Update: Litigations Expand and Key Rulings Expected in 2025" for Medmarc, the leading expert in the products liability risks facing medical technology and life sciences companies. The webinar will take place on May 14, 2025, at 2 pm ET. The event is free of charge and open to the public.
While the COVID-19 pandemic caused tragedy for millions of families worldwide, it has also spurred concomitant advancements in health care, not the least of which include the first-ever regulatory approvals of therapies based on messenger RNA (mRNA) technology granted to Moderna and BioNTech (in collaboration with Pfizer).
At the dawn of this new era in therapeutics, companies operating in this space are eager to develop and commercialize new mRNA-based drugs, but are also faced with the significant challenge of navigating an exceedingly complex IP and competitive landscape involving mRNA and lipid nanoparticle delivery technologies. As a backdrop to these challenges is ongoing high-stakes litigation among major market players which largely began in 2022 based on the sales of the Moderna and BioNTech/Pfizer vaccines that obtained approval to combat the pandemic.
This webinar will provide a detailed update on those cases, including summaries of several key rulings occurring and anticipated this year, and provide analytical frameworks for companies to utilize when navigating this complex space.
To register for this free webinar, please visit the event page on the Medmarc website.
